TCG Advisors’s Biogen BIIB Stock Holding History

TCG Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-23	Closed	-$5K	–	143
2019 Q2	$5K	Buy	23 +14	+156%	+$3.23K	﹤0.01%	311
2019 Q1	$2K	Buy	+9	New	+$2.83K	﹤0.01%	404

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

TCG Advisors's BIIB Position: Q3 2019 in Review

TCG Advisors sold out of Biogen (BIIB) in Q3 2019, closing a stake of 23 shares — an estimated $5K sold.

TCG Advisors first reported a position in BIIB in Q1 2019 and held it in 2 quarters. The position peaked at $5K in Q2 2019. 988 funds tracked by Wall St. Rank hold BIIB as of Q3 2019.

TCG Advisors reported no remaining Biogen position as of Q3 2019 after selling out during the quarter.
TCG Advisors sold 23 Biogen shares in Q3 2019, an estimated $5K.
TCG Advisors first reported a position in Biogen in Q1 2019 and held it in 2 quarters.
TCG Advisors's Biogen position peaked at $5K in Q2 2019.
988 funds tracked by Wall St. Rank held Biogen as of Q3 2019.

Based on TCG Advisors's 13F filing for Q3 2019, filed 13 Nov 2019.